JCR pharmaceuticals logo. Click here to go to the home page
  • Visit JCR Japan
  • Visit JCR Japan
  • Home
  • Who we are
  • Innovation
  • Pipeline
  • Patients & families
  • Our commitment
  • Partnerships
  • Investors & media
  • Our products
  • Contact us

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Chris Miller

JCR Pharmaceuticals presents long-term clinical data on pabinafusp alfa for the treatment of mucopolysaccharidosis type II (MPS II) at ICIEM 2025

by Chris Miller

Notice of orphan drug designation for JR-446 for mucopolysaccharidosis type IIIB by European Commission (EC)

by Chris Miller

  • 1
  • 2
Contact us
JCR pharmaceuticals logo. Click here to go to the home page
  • Sitemap
  • Compliance
  • Privacy policy
  • Global policy
  • Cookie policy
  • Cookie settings

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Privacy Preference Center

Privacy Preferences